Serum CXC ligand 5 is a new marker of subclinical atherosclerosis in type 2 diabetes.
Chen L, Yang Z, Lu B, Li Q, Ye Z, He M, Huang Y, Wang X, Zhang Z, Wen J, Liu C, Qu S, Hu R.
Chen L, et al. Among authors: wen j.
Clin Endocrinol (Oxf). 2011 Dec;75(6):766-70. doi: 10.1111/j.1365-2265.2011.04119.x.
Clin Endocrinol (Oxf). 2011.
PMID: 21609350